Teresa M. Tsakok

St John's Institute Of Dermatology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: March 29, 2026

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Journal: Clinical and translational science

Published: February 18, 2026

Psoriasis at high-impact sites: shifting the paradigm.

Psoriasis at high-impact sites: shifting the paradigm.

Journal: The British journal of dermatology

Published: October 07, 2025

Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study.

Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 21, 2025

Systematic review of deep learning image analyses for the diagnosis and monitoring of skin disease.

Systematic review of deep learning image analyses for the diagnosis and monitoring of skin disease.

Journal: NPJ digital medicine

Published: May 07, 2023

Real-World Implementation and Outcomes of Adalimumab Therapeutic Drug Monitoring in Psoriasis: A National Specialized Center Experience.

Real-World Implementation and Outcomes of Adalimumab Therapeutic Drug Monitoring in Psoriasis: A National Specialized Center Experience.

Journal: The Journal of investigative dermatology

Published: November 16, 2022

Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey.

Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey.

Journal: The British journal of dermatology

Published: September 16, 2022

Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey.

Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey.

Journal: The British journal of dermatology

Published: December 13, 2021

Choosing drugs for UK COVID-19 treatment trials.

Choosing drugs for UK COVID-19 treatment trials.

Journal: Nature reviews. Drug discovery

Published: December 08, 2021

Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove.

Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove.

Journal: JCI insight

Published: November 10, 2021

Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study.

Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 19, 2021

Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.

Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.

Journal: The British journal of dermatology

Published: December 19, 2020

Showing 1-12 of 38

Last Updated: 09/26/2026